HomeProductsBioactive CompoundsMetabolic EnzymesPDECAS 898562-94-2
Chemical structure of CAS 898562-94-2

2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline

In Stock•Starting at $97 for 5 mg•Purity ≥ 99%
CAS No.898562-94-2
MDL No.MFCD28144518
MFC25H20N4O
MW392.50
InChI KeyAZEXWHKOMMASPA-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg99%$97In Stock
10 mg99%$116In Stock
25 mg99%$229In Stock
50 mg99%$388In Stock
100 mg99%$656In Stock
250 mg99%$1245In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.898562-94-2
Product Name2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline

Biological Targets

PDE10A

Associated Conditions

Huntington disease·schizophrenia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging.

Journal of medicinal chemistry • Vol. 54, Issue 16 • 2011
PMID: 21777010DOI: 10.1021/jm200536d

Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A.

Nuclear medicine and biology • Vol. 38, Issue 6 • 2011
PMID: 21843784DOI: 10.1016/j.nucmedbio.2011.02.005

Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain.

Bioorganic & medicinal chemistry • Vol. 19, Issue 5 • 2011
PMID: 21315609PMC: PMC3056285DOI: 10.1016/j.bmc.2011.01.032

The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis.

Journal of neural transmission (Vienna, Austria : 1996) • Vol. 117, Issue 11 • 2010
PMID: 20967473PMC: PMC2993883DOI: 10.1007/s00702-010-0507-3

Documentation

Similar Products